MARKET

CDNA

CDNA

Caredx
NASDAQ
78.56
+2.23
+2.92%
After Hours: 78.00 -0.56 -0.71% 19:49 11/06 EST
OPEN
77.88
PREV CLOSE
76.33
HIGH
80.55
LOW
75.93
VOLUME
1.13M
TURNOVER
--
52 WEEK HIGH
90.87
52 WEEK LOW
14.27
MARKET CAP
4.13B
P/E (TTM)
32.81
1D
5D
1M
3M
1Y
5Y
1D
CareDx (CDNA) Upgraded to Strong Buy: Here's What You Should Know
NASDAQ · 2d ago
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Barchart · 2d ago
Polen 5Perspectives Ultra-Small Growth Q3 2026 Portfolio Review
Seeking Alpha · 4d ago
Baron Discovery Fund Q3 2026 Portfolio Activity
Seeking Alpha · 4d ago
CareDx Q3 Earnings Call Highlights Raised '26 Outlook & Testing Growth
NASDAQ · 5d ago
CareDx Announces Third KOAR Analysis Published in Transplantation
Barchart · 5d ago
Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLY
Seeking Alpha · 6d ago
CareDx price target raised to $90 from $46 at H.C. Wainwright
TipRanks · 6d ago
More
About CDNA
CareDx, Inc. is a precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, the Company is focused on improving patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; digital health technologies; and patient solutions that support care before and after transplant. The Company also provides genomic-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.